News • Lab equipment

Horiba launches D-Dimer hematology reagent

Horiba Medical announces the availability of a D-Dimer reagent for their semi-automated Hemostasis instruments. The D-Dimer is a key measurement and the reference exclusion test for the diagnosis of deep vein thrombosis or pulmonary embolism and may also be used for monitoring Disseminated Intravascular Coagulation.

Source: Horiba

The new Yumizen D-Dimer reagent kit is available for Yumizen G hemostasis instruments - fully automatic (Yumizen G800, Yumizen G1500 & Yumizen G1550) and semi-automatic (Yumizen G200 & Yumizen G400). On Yumizen G semi-automatic systems (Yumizen G200 & Yumizen G400), it offers an innovative combination of immunoturbidimetric test capability and pre-calibrated ready to use reagent.

The new Yumizen D-Dimer reagent kit uses antibody-coated latex particles and is measured with the Immuno-turbidimetric channels of Yumizen G Range instruments, therefore providing fully consistent across the range. It provides laboratories with:

A cost efficient solution:

  • Ready to use liquid format - minimizing preparation time
  • Pre-calibrated reagent avoiding a costly & time-consuming calibration step
  • High stability & optimized volume packaging to avoid wastage

Compliant with Gold Standard performances:

  • Negative Predictive Value 99%
  • Absence of hook effect until 25 µg FEU/ml
  • Slope check and post dilution function (fully automatic & semi-automatic systems)
  • Cut-off value at 0.5 µg FEU/ml


Read all latest stories

Related articles


Sponsored • Haematology analyser

Meet the innovation

The new Yumizen H2500 is a high-end haematology analyser with CBC, 8-DIFF, NRBC, reticulocytes, optical platelets and Body Fluids (CE). Full automation for demanding haematology diagnostics, can be…


News • Diagnostic equpiment

HORIBA Medical launches auto loading hematology system

In order to enhance its hematology portfolio for the small-mid size laboratories segment, HORIBA Medical has developed a new hematology diagnostic solution. The new Yumizen H550 has been designed to…


News • Biomarker from blood test

Lung cancer: Liquid biopsy accurately predicts immunotherapy response

A simple blood test could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure.

Related products

Subscribe to Newsletter